Renaissance Technologies
APTO

Renaissance Technologies’s Aptose Biosciences, Inc. APTO Stock Holding History

Renaissance Technologies’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-713
Closed -$205K – 4413
2023
Q1 		$205K Sell
713
-369
-34% -$107K ﹤0.01% 3267
2022
Q4 		$282K Sell
1,082
-22
-2% -$5.91K ﹤0.01% 3250
2022
Q3 		$296K Buy
1,104
+133
+14% +$45.8K ﹤0.01% 3218
2022
Q2 		$324K Sell
971
-1,199
-55% -$574K ﹤0.01% 3412
2022
Q1 		$1.33M Buy
2,170
+75
+4% +$41.5K ﹤0.01% 2533
2021
Q4 		$1.27M Buy
2,095
+488
+30% +$459K ﹤0.01% 2470
2021
Q3 		$1.58M Buy
+1,607
New +$2.01M ﹤0.01% 2270
2021
Q2 		– Sell
-39
Closed -$105K – 3885
2021
Q1 		$105K Sell
39
-79
-67% -$157K ﹤0.01% 3218
2020
Q4 		$232K Sell
118
-396
-77% -$930K ﹤0.01% 3099
2020
Q3 		$1.38M Sell
514
-263
-34% -$656K ﹤0.01% 2326
2020
Q2 		$2.2M Sell
777
-72
-8% -$232K ﹤0.01% 2140
2020
Q1 		$2.25M Buy
849
+774
+1,032% +$2.31M ﹤0.01% 1994
2019
Q4 		$190K Buy
+75
New +$97.7K ﹤0.01% 3209
2019
Q3 		– Sell
-48
Closed -$56K – 3801
2019
Q2 		$56K Buy
+48
New +$44.2K ﹤0.01% 3446
2018
Q4 		– Sell
-408
Closed -$477K – 3696
2018
Q3 		$477K Buy
408
+375
+1,136% +$503K ﹤0.01% 2862
2018
Q2 		$59K Buy
+33
New +$52.6K ﹤0.01% 3180
2018
Q1 		– Sell
-60
Closed -$59K – 3645
2017
Q4 		$59K Sell
60
-9
-13% -$6.96K ﹤0.01% 3254
2017
Q3 		$46K Hold
69
– – ﹤0.01% 3131
2017
Q2 		$39K Buy
69
+14
+25% +$6.74K ﹤0.01% 3136
2017
Q1 		$25K Buy
+55
New +$28.2K ﹤0.01% 3170

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies's APTO Position: Q2 2023 in Review

Renaissance Technologies sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 713 shares — an estimated $205K sold.

Renaissance Technologies first reported a position in APTO in Q1 2017 and held it in 20 quarters. The position peaked at $2.25M in Q1 2020. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • Renaissance Technologies reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 713 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $205K.
  • Renaissance Technologies first reported a position in Aptose Biosciences, Inc. in Q1 2017 and held it in 20 quarters.
  • Renaissance Technologies's Aptose Biosciences, Inc. position peaked at $2.25M in Q1 2020.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.